QNRX · NASDAQ
Quoin Pharmaceuticals (QNRX) Stock Price & Fundamentals
Quoin Pharmaceuticals (QNRX) closed at $488.94 on Oct 9, 2026, down 0.19% from the previous close of $489.89.
Share price, past year
1Y +14.27%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $488.94 |
| Sep 30, 2026 | $478.94 |
| Aug 31, 2026 | $456.27 |
| Jul 31, 2026 | $451.59 |
| Jun 30, 2026 | $435.78 |
| May 29, 2026 | $440.08 |
| Apr 30, 2026 | $455.01 |
| Mar 31, 2026 | $460.43 |
| Feb 27, 2026 | $456.69 |
| Jan 30, 2026 | $452.70 |
| Dec 31, 2025 | $469.98 |
| Nov 28, 2025 | $445.71 |
| Oct 31, 2025 | $408.25 |
Key statistics
- Market cap
- $34.37B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$18.67M
- Shares outstanding
- 70.3M
- Dividend yield
- —
- 52-week range
- $405.11 – $489.89
Quoin Pharmaceuticals's market cap is $34.37B, based on a share price of $488.94 and 70.3M shares outstanding as of Jun 30, 2026.
Financials
Quoin Pharmaceuticals reported revenue of $0.00 for fiscal 2021.
Quoin Pharmaceuticals reported a net loss of $15.80M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2021ended Dec 31, 2021 | $0.00 | — | −$21.46M | — | −$0.01 | — |
| FY2020ended Dec 31, 2020 | $0.00 | — | −$2.10M | — | −$0.70 | — |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$1.56M | — | −$0.52 | — |
Company profile
- Name
- Quoin Pharmaceuticals Ltd.
- Ticker
- QNRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 42127 Pleasant Forest Court, Ashburn, VA 20148-7349
- Incorporated in
- L3
- SEC CIK
- 0001671502
Recent SEC filings
- Sep 22, 2026
- Sep 10, 2026
- Aug 28, 2026
- Aug 20, 2026
- Aug 14, 2026
- Aug 14, 2026
- Jun 23, 2026
- Jun 4, 2026
Frequently asked questions
What is Quoin Pharmaceuticals's stock price?
Quoin Pharmaceuticals (QNRX) closed at $488.94 on Oct 9, 2026, down 0.19% from the previous close of $489.89.
What is Quoin Pharmaceuticals's market cap?
Quoin Pharmaceuticals's market cap is $34.37B, based on a share price of $488.94 and 70.3M shares outstanding as of Jun 30, 2026.
How much revenue does Quoin Pharmaceuticals make?
Quoin Pharmaceuticals reported revenue of $0.00 for fiscal 2021.
Does Quoin Pharmaceuticals pay a dividend?
Quoin Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Quoin Pharmaceuticals Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures